Heidenhain has introduced the ROD 1930 rotary encoder series for use in mechanically-demanding motion control environments. With exceptionally rugged bearings, this new incremental encoder can withstand radial shaft loads of 200 N and axial shaft loads of 150 N.
ams has announced next-generation sensor-enabled RFID tags offering breakthroughs for medical, automotive safety and other applications where temperature, physiological or environmental data is required. The new devices, the SL13A and SL900A enable a simple, low-cost implementation of a new class of wireless data-logging applications.
Phoenix Display International (PDI) has introduced a family of TFT monochrome LCDs that provide a drop-in replacement for passive matrix monochrome displays with superior performance, including higher brightness, wider viewing angles, higher contrast ratios, faster response times, higher resolution, sunlight readability and wider operating temperatures.
Small but meticulous—allshape AG in Lengnau, Switzerland, near Biel specializes in high-precision products for all common shapes of dental implants. Thanks to the reliable Sinumerik 840D CNC, allshape AG gives dental laboratories customized and fast delivery service.
The buzz around wearable technology has been escalating the past several months. In fact, wearable technology has moved beyond product concepts to actual products worn by consumers. These include virtual reality eyeglasses, sophisticated health monitoring devices housed within an elastic wristband, sensor-based canes for the blind, and smartwatches with many features.
The WaveCrest LAA Occluder is an implantable device that seals off the LAA opening so clots cannot escape into the blood stream and cause a stroke. It is a one-time treatment option for patients who would otherwise be on a lifetime regimen of anticoagulation therapy.
Coherex Medical Inc. announced it has received CE Mark approval for its Coherex WaveCrest LAA Occlusion System. Atrial fibrillation (AF) is the most common cardiac arrhythmia in today’s aging population, effecting nearly 6 million individuals in the US alone.
Florida Hospital Collaborates with VTT of Finland to Explore Research for Early Detection of Alzheimer’s DiseaseSeptember 19, 2013 11:36 am | by Technical Research Centre of Finland (VTT) | News | Comments
In an effort to better understand the development of Alzheimer’s disease, Florida Hospital Neuroscience Institute and VTT Technical Research Centre of Finland are collaborating to identify the biomarker assay that may predict early onsets of the disease.
The researchers have developed a method that improves the delimitation of tumors in medical images. As they explained, “when the doctor decides where tumor tissue should be separated from healthy tissue, our algorithm ensures that he/she is never going choose the worst option because the best solution is automatically offered.”
A lens invented at The Ohio State University combines the focusing ability of a human eye with the wide-angle view of an insect eye to capture images with depth. The results could offer surgical imaging that enables doctors to see inside the human body like never before.
A lens invented at The Ohio State University combines the focusing ability of a human eye with the wide-angle view of an insect eye to capture images with depth. The results could be smartphones that rival the photo quality of digital cameras, and surgical imaging that enables doctors to see inside the human body like never before.
The CE marked TriGuard is the only device designed to cover all three aortic cerebral branches to minimize the risk of cerebral damage during Transcatheter Aortic Valve Replacement (TAVR) and other cardiovascular procedures. It is the only system designed for placement via one of two femoral artery access ports.
Covidien said its board of directors authorized a restructuring plan aimed at saving up to $300 million a year by fiscal 2018, with manufacturing and distribution operations slated to be closed. Covidien did not reveal how many layoffs would be involved.
A handheld device for diagnosing the early signs of osteoporosis could be available for clinical use within five years. The technology is currently being refined and tested at the University of Southampton with support from the Engineering and Physical Sciences Research Council (EPSRC).
Medical device maker Boston Scientific (NYSE:BSX) issued new warnings on its Cognis and Teligen implantable cardioverter defibrillators, advising physicians to watch out for premature battery depletion in older models. The problematic implants are no longer available and haven't been manufactured since December 2009...